Tolerance Bio Inc. filed a Form D with the Securities and Exchange Commission on 2026-06-18.
Tolerance Bio Inc. filed a Form D notice of an exempt securities offering with the SEC on June 18, 2026. The filing reports $15.10M sold. Its industry group is Biotechnology. It names Francisco Leon (Executive Officer, Director), Justin Vogel (Executive Officer, Director), Damia Carulla (Director) (SEC Form D, June 18, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Tolerance Bio Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-06-18 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Tolerance Bio Inc.
Free to see. No signup.
More on the people and the money behind Tolerance Bio Inc., from the filings we hold.
Biotechnology raises by companies based in Pennsylvania, filed within 90 days of this one, largest first.
Get an email when Tolerance Bio Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Tolerance Bio Inc. raises, hires or launches. No email unless you switch it on.
Watch Tolerance Bio Inc. →Get the full cited report on Tolerance Bio Inc.
What the filing shows about Tolerance Bio Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Tolerance Bio Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Tolerance Bio Inc.'s address as 2929 Arch Street, 4TH Floor, Philadelphia, PA 19104.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Tolerance Bio Inc. is a registered filer with the SEC (CIK 2075488) and has filed since 2026-06-18. 1 filing is on record, the latest on 2026-06-18.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Tolerance Bio Inc.'s Form D of 2026-06-18 names Francisco Leon, Justin Vogel, Damia Carulla and 3 more as its officers, directors or promoters.
Its new offerings report $15.10M sold across 1 offering, as its own filings state.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $15.10M, on the same scale — one filing against the whole group's total, so it sits low by construction.
The proceeds of the offering will be used for general corporate purposes.
Checked away from the filing. What is below does not come from the record on sec.gov.
Tolerance Bio will increase health span by preserving and restoring the function of the thymus, the master regulator of immune tolerance. Immune-mediated diseases represent a significant unmet medical challenge: cancer, autoimmunity, transplant rejection, infections, immune deficiencies, and allergies.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Francisco Leon is named as Executive Officer and Director on the Form D that Tolerance Bio Inc. filed with the SEC on 18 June 2026, one of 6 people that filing names.
Justin Vogel is named as Executive Officer and Director on the Form D that Tolerance Bio Inc. filed with the SEC on 18 June 2026, one of 6 people that filing names.
Damia Carulla is named as Director on the Form D that Tolerance Bio Inc. filed with the SEC on 18 June 2026, one of 6 people that filing names.
Robert Goldstein is named as Director on the Form D that Tolerance Bio Inc. filed with the SEC on 18 June 2026, one of 6 people that filing names.
Philip Ball is named as Executive Officer and Director on the Form D that Tolerance Bio Inc. filed with the SEC on 18 June 2026, one of 6 people that filing names.
Pablo Cironi is named as Director on the Form D that Tolerance Bio Inc. filed with the SEC on 18 June 2026, one of 6 people that filing names.
6 people named on the filing — 3 holding an executive role and 3 as directors only.
Named as of the 2026-06-18 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Tolerance Bio Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Tolerance Bio Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Tolerance Bio Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Tolerance Bio Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Tolerance Bio Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-26 (tolerancebio.com).
Each opens in a new tab, filled in for Tolerance Bio Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Philadelphia
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/tolerance-bio-inc-form-d-26029282